These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s]. Magnusson C; Reeves G Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095 [No Abstract] [Full Text] [Related]
3. Justification for the use of HRT in the long-term prevention of osteoporosis. Stevenson JC Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151 [TBL] [Abstract][Full Text] [Related]
4. Hormone therapy and breast cancer risk. Foidart JM; Desreux J; Pintiaux A; Gompel A Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674 [TBL] [Abstract][Full Text] [Related]
5. Use of dydrogesterone in hormone replacement therapy. Mueck AO; Seeger H; Bühling KJ Maturitas; 2009 Dec; 65 Suppl 1():S51-60. PubMed ID: 19836909 [TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and risk of breast cancer: the role of progestins. Stahlberg C; Pedersen AT; Lynge E; Ottesen B Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318 [TBL] [Abstract][Full Text] [Related]
7. Landmark hormone replacement therapy study stopped after finding more harms than benefits. Rollins G Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323 [No Abstract] [Full Text] [Related]
8. Postmenopausal hormone replacement therapy: does the progestin make a difference? Fylstra DL J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600 [No Abstract] [Full Text] [Related]
9. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same]. Ribot C; Trémollieres F Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010 [TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy in menopause and lung cancer: an update. La Vecchia C Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859 [No Abstract] [Full Text] [Related]
11. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use]. Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514 [TBL] [Abstract][Full Text] [Related]
12. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J; J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505 [TBL] [Abstract][Full Text] [Related]
13. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer]. Magnusson C; Weiderpass E Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082 [TBL] [Abstract][Full Text] [Related]
14. Androgenic progestins amplify the breast cancer risk associated with hormone replacement therapy by boosting IGF-I activity. McCarty MF Med Hypotheses; 2001 Feb; 56(2):213-6. PubMed ID: 11425289 [TBL] [Abstract][Full Text] [Related]
15. [New insights on the effects of hormone replacement therapy on the breast tissue and the orgnaism]. Kubista E Wien Klin Wochenschr; 2003; 115 Suppl 2():46-9. PubMed ID: 15518146 [TBL] [Abstract][Full Text] [Related]
16. [Hormone replacement therapy and the risk of developing breast cancer]. Merz WE MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702 [TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone therapy and breast cancer. Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723 [TBL] [Abstract][Full Text] [Related]
19. Estrogen and progestogen therapy in postmenopausal women. Practice Committee of American Society for Reproductive Medicine Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655 [TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden. Shah NR Cancer; 2003 Oct; 98(7):1552-3; author reply 1553. PubMed ID: 14508845 [No Abstract] [Full Text] [Related] [Next] [New Search]